Digital & Technology Compliance
Computer Software Assurance
Risk-based computer software assurance services for pharmaceutical and medical device organisations — CSA framework design, SaaS qualification, GAMP 5 assessments and Annex 11 compliance reviews aligned to current FDA and EU expectations.
Executive Overview
The FDA's 2022 Computer Software Assurance guidance represents the most significant shift in the regulatory approach to software in regulated environments since the original 21 CFR Part 11 guidance of the 1990s. CSA moves the regulatory expectation away from documentation-heavy validation protocols toward a risk-based, outcome-focused assurance model that reflects how modern software is actually developed, deployed and maintained.
For organisations still operating CSV programmes built around legacy IQ/OQ/PQ frameworks, the transition to CSA requires both a conceptual shift and a practical programme update. Systems must be reclassified based on their actual GxP impact, testing strategies must be redesigned to leverage automation and vendor evidence, and documentation requirements must be rebuilt around demonstrating fitness for intended use rather than protocol execution.
Sthira Assure supports pharmaceutical, biotechnology and medical device organisations through the full CSA transition — from initial readiness assessment and gap analysis through to framework design, SaaS system qualification and ongoing programme management. Our approach is grounded in current FDA CSA guidance, GAMP 5 second edition and EU GMP Annex 11, providing assurance programmes that are defensible to regulators across multiple jurisdictions.
Regulatory Frameworks
- FDA CSA Guidance 2022
- EU GMP Annex 11
- GAMP 5 (2nd Edition)
- 21 CFR Part 11
- EU GMP Annex 21 (Importation)
- ISO 13485 (Medical Devices)
- ISPE GAMP Guidelines
Discuss CSA Requirements
Speak with our team about your software systems and current compliance posture.
Request a ConsultationCommon Compliance Risks
Over-reliance on Legacy CSV Approaches
Traditional computer system validation frameworks built around IQ/OQ/PQ protocols and extensive documentation burden are not aligned to FDA's current CSA thinking. Organisations that continue to apply legacy validation approaches to modern cloud-based and SaaS systems create disproportionate documentation overhead with limited compliance benefit, while also being poorly positioned for future regulatory scrutiny.
SaaS and Cloud System Qualification Gaps
Cloud-based and SaaS systems present distinct qualification challenges. Shared infrastructure, multi-tenancy arrangements, frequent vendor-driven updates and limited access to underlying code require tailored qualification strategies. Many organisations apply traditional CSV approaches to SaaS systems that are neither practical nor aligned to how these systems operate, resulting in inadequate assurance or unsustainable documentation burdens.
Insufficient Risk Classification
Effective CSA depends on accurate risk classification of computer systems based on their GxP impact. Organisations that over-classify low-risk systems create unnecessary validation overhead; those that under-classify high-risk systems expose themselves to data integrity vulnerabilities and inspection findings. Risk classification must be systematic, documented and defensible to regulators.
Vendor Update Management Failures
SaaS and cloud vendors deploy updates frequently and often with limited notice. Organisations that do not have robust processes for assessing the GxP impact of vendor updates, determining whether requalification is required and documenting their assessment decisions accumulate unmanaged compliance risk with each update cycle. This is among the most common inspection observations for organisations using modern software systems.
Scope of Services
Our CSA services cover the transition from legacy CSV frameworks through to full CSA programme implementation, including system-level qualification and ongoing compliance management.
Typical Deliverables
Frequently Asked Questions
What is the difference between CSV and CSA?
Computer System Validation (CSV) is the traditional approach requiring extensive documentation, IQ/OQ/PQ protocols and often significant manual testing effort. Computer Software Assurance (CSA) is the FDA's updated approach, articulated in the 2022 draft guidance, which shifts focus from documentation burden to activities that actually ensure software is fit for intended use. CSA emphasises risk-based thinking, automated testing, leveraging vendor testing and focusing effort on high-risk systems and functions.
Is CSA applicable in Europe as well as the US?
The CSA concept originated from the FDA, but the underlying risk-based principles are consistent with EU GMP Annex 11 and the GAMP 5 second edition. GAMP 5 (2022) explicitly moved toward a more risk-based, outcome-focused approach that aligns closely with CSA thinking. Organisations subject to both FDA and EU requirements can implement CSA frameworks that satisfy both regulatory environments.
How do you approach qualification of frequently updated SaaS systems?
We design periodic review and change impact assessment frameworks that allow organisations to manage SaaS system updates without triggering full requalification for every release. The approach includes vendor update monitoring, risk-based impact assessment procedures and a defined decision tree for determining when requalification activities are required. This reduces the compliance burden of frequent updates while maintaining regulatory defensibility.
What documentation is required under CSA?
CSA does not eliminate documentation — it refocuses it. Required documentation includes system risk assessment, intended use definition, critical quality attributes and critical process parameters affected by the system, supplier assessment, key testing evidence and ongoing monitoring approach. The key shift is that documentation should demonstrate the outcome of assurance activities, not simply record that traditional protocol steps were executed.
Discuss Your CSA Programme
Contact our team to discuss your current software validation approach, transition requirements and the CSA framework your organisation needs.